$CORT
Corcept Therapeutics Inc

2019 Q2 Form 10-Q Financial Statement

#000162828019009802 Filed on August 01, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2
Revenue $72.26M $62.31M
YoY Change 15.96% 75.24%
Cost Of Revenue $1.377M $1.154M
YoY Change 19.32% 48.9%
Gross Profit $70.88M $61.16M
YoY Change 15.9% 75.82%
Gross Profit Margin 98.09% 98.15%
Selling, General & Admin $24.59M $19.98M
YoY Change 23.07% 41.58%
% of Gross Profit 34.69% 32.67%
Research & Development $21.66M $20.54M
YoY Change 5.42% 160.7%
% of Gross Profit 30.55% 33.59%
Depreciation & Amortization $200.0K $100.0K
YoY Change 100.0%
% of Gross Profit 0.28% 0.16%
Operating Expenses $46.25M $40.52M
YoY Change 14.12% 187.14%
Operating Profit $24.63M $20.63M
YoY Change 19.38% 61.27%
Interest Expense $1.180M $560.0K
YoY Change 110.71% -473.33%
% of Operating Profit 4.79% 2.71%
Other Income/Expense, Net $1.178M $562.0K
YoY Change 109.61% 1024.0%
Pretax Income $25.81M $21.20M
YoY Change 21.77% 66.94%
Income Tax $5.600M $3.000M
% Of Pretax Income 21.7% 14.15%
Net Earnings $20.19M $18.20M
YoY Change 10.94% 43.88%
Net Earnings / Revenue 27.94% 29.2%
Basic Earnings Per Share $0.18 $0.16
Diluted Earnings Per Share $0.17 $0.14
COMMON SHARES
Basic Shares Outstanding 114.3M shares 115.5M shares
Diluted Shares Outstanding 121.8M shares 127.5M shares

Balance Sheet

Concept 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $201.5M $159.9M
YoY Change 26.02% 141.54%
Cash & Equivalents $58.14M $31.17M
Short-Term Investments $143.4M $128.8M
Other Short-Term Assets $6.200M $3.600M
YoY Change 72.22% 44.0%
Inventory $5.142M $4.947M
Prepaid Expenses
Receivables $19.77M $28.70M
Other Receivables $0.00 $0.00
Total Short-Term Assets $232.7M $197.2M
YoY Change 17.99% 142.53%
LONG-TERM ASSETS
Property, Plant & Equipment $1.177M $552.0K
YoY Change 113.22% 10.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $24.20M $0.00
YoY Change -100.0%
Other Assets $150.0K $76.70M
YoY Change -99.8% 156430.61%
Total Long-Term Assets $96.02M $77.21M
YoY Change 24.37% 1384.75%
TOTAL ASSETS
Total Short-Term Assets $232.7M $197.2M
Total Long-Term Assets $96.02M $77.21M
Total Assets $328.7M $274.4M
YoY Change 19.79% 217.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.026M $6.365M
YoY Change 10.38% 203.1%
Accrued Expenses $16.44M $19.11M
YoY Change -13.99% 39.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $30.38M $30.87M
YoY Change -1.59% 51.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $200.0K
YoY Change
Total Long-Term Liabilities $200.0K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $30.38M $30.87M
Total Long-Term Liabilities $200.0K $0.00
Total Liabilities $30.63M $30.90M
YoY Change -0.89% 51.47%
SHAREHOLDERS EQUITY
Retained Earnings -$79.28M -$157.5M
YoY Change -49.66%
Common Stock $436.7M $401.1M
YoY Change 8.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $298.1M $243.5M
YoY Change
Total Liabilities & Shareholders Equity $328.7M $274.4M
YoY Change 19.79% 217.2%

Cashflow Statement

Concept 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income $20.19M $18.20M
YoY Change 10.94% 43.88%
Depreciation, Depletion And Amortization $200.0K $100.0K
YoY Change 100.0%
Cash From Operating Activities $25.50M $15.20M
YoY Change 67.76% -1.94%
INVESTING ACTIVITIES
Capital Expenditures -$400.0K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$800.0K -$21.20M
YoY Change -96.23% 43.24%
Cash From Investing Activities -$1.100M -$21.20M
YoY Change -94.81% 41.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -15.90M 4.100M
YoY Change -487.8% -182.0%
NET CHANGE
Cash From Operating Activities 25.50M 15.20M
Cash From Investing Activities -1.100M -21.20M
Cash From Financing Activities -15.90M 4.100M
Net Change In Cash 8.500M -1.900M
YoY Change -547.37% -57.78%
FREE CASH FLOW
Cash From Operating Activities $25.50M $15.20M
Capital Expenditures -$400.0K $0.00
Free Cash Flow $25.90M $15.20M
YoY Change 70.39% -3.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Central Index Key
EntityCentralIndexKey
0001088856
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-7000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
41000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-73000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-124000 USD
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-50679
dei Entity Registrant Name
EntityRegistrantName
CORCEPT THERAPEUTICS INC
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0487658
dei Entity Address Address Line1
EntityAddressAddressLine1
149 Commonwealth Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Menlo Park
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94025
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
327-3270
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
CORT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
113688837 shares
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58141000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41625000 USD
CY2019Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
143396000 USD
CY2018Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
165135000 USD
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19774000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17588000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
5142000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
4732000 USD
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6202000 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7740000 USD
CY2019Q2 us-gaap Assets Current
AssetsCurrent
232655000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
236820000 USD
CY2019Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
12726000 USD
CY2018Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
11510000 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1106000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1177000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
655000 USD
CY2019Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
24165000 USD
CY2018Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
0 USD
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
150000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
50000 USD
CY2019Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
56700000 USD
CY2018Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
62659000 USD
CY2019Q2 us-gaap Assets
Assets
328679000 USD
CY2018Q4 us-gaap Assets
Assets
311694000 USD
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
7026000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8266000 USD
CY2019Q2 cort Accrued Clinical Expenses Current
AccruedClinicalExpensesCurrent
5770000 USD
CY2018Q4 cort Accrued Clinical Expenses Current
AccruedClinicalExpensesCurrent
3521000 USD
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16437000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23786000 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1148000 USD
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
30381000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
35573000 USD
CY2019Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
245000 USD
CY2018Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
239000 USD
CY2019Q2 us-gaap Liabilities
Liabilities
30626000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
35812000 USD
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
118000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
117000 USD
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
436622000 USD
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
417228000 USD
CY2019Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
59732000 USD
CY2018Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
23657000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
321000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-70000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-79276000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-117736000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
298053000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
275882000 USD
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
328679000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
311694000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
72257000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
62312000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
137086000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
119971000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1377000 USD
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1154000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2617000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2328000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21656000 USD
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20543000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41900000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37593000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24591000 USD
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19981000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48980000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
38421000 USD
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
47624000 USD
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
41678000 USD
us-gaap Costs And Expenses
CostsAndExpenses
93497000 USD
us-gaap Costs And Expenses
CostsAndExpenses
78342000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
24633000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
20634000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
43589000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
41629000 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1178000 USD
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
562000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2275000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5834000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5642000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
856000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
25811000 USD
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
21196000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
45864000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
42485000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5625000 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7404000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6830000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
20186000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
18196000 USD
us-gaap Net Income Loss
NetIncomeLoss
38460000 USD
us-gaap Net Income Loss
NetIncomeLoss
35655000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
227000 USD
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
25000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
391000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-127000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20413000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18221000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
38851000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
35528000 USD
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114340000 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115492000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114590000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115189000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121783000 shares
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127515000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
122831000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127610000 shares
us-gaap Profit Loss
ProfitLoss
38460000 USD
us-gaap Profit Loss
ProfitLoss
35655000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
14432000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10971000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
140000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
95664000 USD
us-gaap Interest Income Debt Securities Available For Sale Operating
InterestIncomeDebtSecuritiesAvailableForSaleOperating
1053000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
130145000 USD
us-gaap Interest Income Debt Securities Available For Sale Operating
InterestIncomeDebtSecuritiesAvailableForSaleOperating
546000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
263000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
49641000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
667000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
105000 USD
cort Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
772000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2186000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13404000 USD
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
0 USD
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-12896000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1543000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2071000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1538000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
910000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
100000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1299000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2214000 USD
cort Increase Decrease In Accrued Clinical Expenses
IncreaseDecreaseInAccruedClinicalExpenses
2197000 USD
cort Increase Decrease In Accrued Clinical Expenses
IncreaseDecreaseInAccruedClinicalExpenses
3150000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-7349000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
370000 USD
cort Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-730000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
49236000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
40300000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
131001000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1523000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-55504000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3947000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5966000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
30975000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4169000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-31197000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5966000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16516000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
103000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41625000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31062000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58141000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127610000 shares
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
13555000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
18274000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
285755000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31165000 USD
cort Shares Repurchased In Net Settlement Of Cashless Option Exercise
SharesRepurchasedInNetSettlementOfCashlessOptionExercise
931000 USD
cort Shares Repurchased In Net Settlement Of Cashless Option Exercise
SharesRepurchasedInNetSettlementOfCashlessOptionExercise
0 USD
cort Non Cash Transaction Recognition Of Right Of Use Asset And Lease Liability
NonCashTransactionRecognitionOfRightOfUseAssetAndLeaseLiability
1878000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
190968000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1922000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4954000 USD
CY2018Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-77000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
17459000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
215226000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4044000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6017000 USD
CY2018Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
24000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
18196000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
243507000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
275882000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3366000 USD
CY2019Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5100000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6724000 USD
CY2019Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
164000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1514000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7791000 USD
CY2019Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
227000 USD
CY2019Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
17420000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
20186000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
298053000 USD
cort Number Of Series Of Selective Cortisol Modulators
NumberOfSeriesOfSelectiveCortisolModulators
3 series
CY2018 cort Number Of Compounds
NumberOfCompounds
500 compound
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2019Q2 cort Inventory Raw Materials Current And Noncurrent
InventoryRawMaterialsCurrentAndNoncurrent
7395000 USD
CY2018Q4 cort Inventory Raw Materials Current And Noncurrent
InventoryRawMaterialsCurrentAndNoncurrent
4195000 USD
CY2019Q2 cort Inventory Work In Process Current And Noncurrent
InventoryWorkInProcessCurrentAndNoncurrent
5271000 USD
CY2018Q4 cort Inventory Work In Process Current And Noncurrent
InventoryWorkInProcessCurrentAndNoncurrent
5624000 USD
CY2019Q2 cort Inventory Finished Goods Current And Noncurrent
InventoryFinishedGoodsCurrentAndNoncurrent
5202000 USD
CY2018Q4 cort Inventory Finished Goods Current And Noncurrent
InventoryFinishedGoodsCurrentAndNoncurrent
6423000 USD
CY2019Q2 cort Inventory Current Noncurrent
InventoryCurrentNoncurrent
17868000 USD
CY2018Q4 cort Inventory Current Noncurrent
InventoryCurrentNoncurrent
16242000 USD
CY2019Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
12726000 USD
CY2018Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
11510000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
5142000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
4732000 USD
CY2019Q2 cort Accrued Government Rebate Current
AccruedGovernmentRebateCurrent
7688000 USD
CY2018Q4 cort Accrued Government Rebate Current
AccruedGovernmentRebateCurrent
11132000 USD
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5083000 USD
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7879000 USD
CY2019Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1275000 USD
CY2018Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
261000 USD
CY2019Q2 cort Accrued Legal Fees Current
AccruedLegalFeesCurrent
967000 USD
CY2018Q4 cort Accrued Legal Fees Current
AccruedLegalFeesCurrent
314000 USD
CY2019Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
694000 USD
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
240000 USD
CY2019Q2 cort Accrued Manufacturing Costs
AccruedManufacturingCosts
261000 USD
CY2018Q4 cort Accrued Manufacturing Costs
AccruedManufacturingCosts
2032000 USD
CY2019Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2018Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1542000 USD
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
469000 USD
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
386000 USD
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16437000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23786000 USD
CY2019Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
210830000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
192210000 USD
cort Marketable Securities Maximum Maturity Period
MarketableSecuritiesMaximumMaturityPeriod
P2Y
cort Marketable Securities Weighted Average Maturity Period
MarketableSecuritiesWeightedAverageMaturityPeriod
P6M
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
400000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
800000 USD
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
391000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
769000 USD
CY2019Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9M
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9M
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.050
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.050
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
781000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
391000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1172000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
24000 USD
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1148000 USD
CY2019Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 USD
us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
0 USD
cort Number Of Stock Option Plans
NumberOfStockOptionPlans
2 stock_option_plan
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
122831000 shares
CY2019Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
55000 USD
CY2018Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
83000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 USD
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
7791000 USD
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
6017000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
14515000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
10971000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
20186000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
18196000 USD
us-gaap Net Income Loss
NetIncomeLoss
38460000 USD
us-gaap Net Income Loss
NetIncomeLoss
35655000 USD
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114340000 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115492000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114590000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115189000 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7443000 shares
CY2018Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
12023000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8241000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
12421000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121783000 shares
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127515000 shares
us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
1600000 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000000.0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6800000 USD
CY2018Q2 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-2500000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-5600000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
24700000 shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
23000000.0 shares
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5600000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7400000 USD
CY2019Q2 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
300000 USD
us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
3200000 USD
CY2019Q2 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-4900000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-5800000 USD
CY2019Q2 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
700000 USD
CY2018Q2 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
500000 USD
us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
1200000 USD

Files In Submission

Name View Source Status
0001628280-19-009802-index-headers.html Edgar Link pending
0001628280-19-009802-index.html Edgar Link pending
0001628280-19-009802.txt Edgar Link pending
0001628280-19-009802-xbrl.zip Edgar Link pending
cort-20190630.xsd Edgar Link pending
cort-20190630_cal.xml Edgar Link unprocessable
cort-20190630_def.xml Edgar Link unprocessable
cort-20190630_lab.xml Edgar Link unprocessable
cort-20190630_pre.xml Edgar Link unprocessable
cort6301910-qdoc.htm Edgar Link pending
cort6301910-qdoc_htm.xml Edgar Link completed
cort63019ex311.htm Edgar Link pending
cort63019ex312.htm Edgar Link pending
cort63019ex321.htm Edgar Link pending
cort63019ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending